[go: up one dir, main page]

MX2015010315A - Fabricacion de formulaciones de mani para desensibilizacion oral. - Google Patents

Fabricacion de formulaciones de mani para desensibilizacion oral.

Info

Publication number
MX2015010315A
MX2015010315A MX2015010315A MX2015010315A MX2015010315A MX 2015010315 A MX2015010315 A MX 2015010315A MX 2015010315 A MX2015010315 A MX 2015010315A MX 2015010315 A MX2015010315 A MX 2015010315A MX 2015010315 A MX2015010315 A MX 2015010315A
Authority
MX
Mexico
Prior art keywords
peanut
manufacture
oral desensitization
formulations
oral
Prior art date
Application number
MX2015010315A
Other languages
English (en)
Inventor
Bryan Walser
Howard V Raff
Original Assignee
Aimmune Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51528061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2015010315(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aimmune Therapeutics Inc filed Critical Aimmune Therapeutics Inc
Publication of MX2015010315A publication Critical patent/MX2015010315A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Pulmonology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La presente solicitud se relaciona a un método para el manejo del proceso de fabricación y desarrollo de una formulación terapéuticamente efectiva. Las proteínas de maní se caracterizan de harina de maní y formulaciones encapsuladas hechas utilizando la harina de maní para la inmunoterapia oral de alergias al maní.
MX2015010315A 2013-03-14 2014-03-12 Fabricacion de formulaciones de mani para desensibilizacion oral. MX2015010315A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361784964P 2013-03-14 2013-03-14
PCT/US2014/024401 WO2014159607A1 (en) 2013-03-14 2014-03-12 Manufacture of peanut formulations for oral desensitization

Publications (1)

Publication Number Publication Date
MX2015010315A true MX2015010315A (es) 2016-04-13

Family

ID=51528061

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015010315A MX2015010315A (es) 2013-03-14 2014-03-12 Fabricacion de formulaciones de mani para desensibilizacion oral.

Country Status (18)

Country Link
US (5) US9198869B2 (es)
EP (3) EP3998080A1 (es)
JP (3) JP6752140B2 (es)
CN (2) CN105101994B (es)
AU (5) AU2014240404B2 (es)
BR (1) BR112015021756B1 (es)
CA (1) CA2903229A1 (es)
DK (2) DK2968529T3 (es)
ES (2) ES2826224T3 (es)
FI (2) FI3482771T3 (es)
FR (1) FR23C1026I2 (es)
HU (1) HUE051831T2 (es)
MX (1) MX2015010315A (es)
NO (1) NO2023027I1 (es)
PL (1) PL2968529T3 (es)
PT (1) PT2968529T (es)
SI (1) SI2968529T1 (es)
WO (1) WO2014159607A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
PL2968529T3 (pl) 2013-03-14 2021-04-19 Aimmune Therapeutics, Inc. Wytwarzanie formulacji orzeszków ziemnych do doustnego odczulania
US11197896B2 (en) 2014-08-25 2021-12-14 Société des Produits Nestlé S.A. Egg protein formulations and methods of manufacture thereof
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
CA2977127A1 (en) 2015-02-20 2016-08-25 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
TW201709926A (zh) * 2015-04-23 2017-03-16 賽諾菲公司 用於舌下投藥之吡喃葡萄糖基脂ａ及過敏原調配物
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
CA3044905A1 (en) * 2016-12-05 2018-06-14 Reacta Biotech Limited Oral food challenge meal formulations
CN110381749A (zh) * 2017-01-13 2019-10-25 艾慕恩治疗公司 坚果粉的制造方法和用于口服免疫疗法的配方
BR102017026619A2 (pt) 2017-02-15 2018-10-30 Euroimmun Medizinische Labordiagnostika Ag ensaio melhorado para a diagnose de alergia a amendoim
WO2019018529A1 (en) 2017-07-18 2019-01-24 Before Brands, Inc. METHODS OF MAKING MIXED ALLERGEN COMPOSITIONS
KR102753602B1 (ko) 2017-11-02 2025-01-10 에이뮨 테라퓨틱스, 인코퍼레이티드 경구 면역요법 방법
GB201718342D0 (en) 2017-11-06 2017-12-20 Cambridge Allergy Ltd Allergenic protein formulations for immunotherapy
IL276121B1 (en) 2018-01-16 2025-04-01 Sheba Impact Ltd Treatment and prevention of seed allergies
WO2020023925A1 (en) 2018-07-27 2020-01-30 Aimmune Therapeutics, Inc. Oral immunotherapy unit dose dispensing systems and methods
CA3122854A1 (en) * 2018-12-17 2020-06-25 Aimmune Therapeutics, Inc. Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy
WO2020132341A1 (en) 2018-12-20 2020-06-25 Aimmune Therapeutics, Inc. Peanut oral immunotherapy dosing schedule for missed doses
WO2020154476A1 (en) 2019-01-23 2020-07-30 Before Brands, Inc. Methods for making mixed allergen compositions
CN113966229A (zh) 2019-05-10 2022-01-21 爱沐疗法公司 用于改善花生过敏患者的生活质量的方法
AU2020324553A1 (en) * 2019-08-08 2022-03-24 Evonik Operations Gmbh Method of preparing a solid dosage form and a lubricant
US20210151155A1 (en) * 2019-11-20 2021-05-20 Aimmune Therapeutics, Inc. Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug
KR20220119076A (ko) * 2019-12-23 2022-08-26 프로타 테라퓨틱스 피티와이 엘티디 약학적 조성물
CA3182901A1 (en) 2020-07-01 2022-01-06 Hans CHUANG Determining medical staffing for oral immunotherapy
US20220220211A1 (en) 2021-01-08 2022-07-14 Regeneron Pharmaceuticals, Inc. Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist
AU2023253754A1 (en) 2022-04-11 2024-10-17 Alk-Abelló A/S Peanut allergen composition

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3809767A (en) * 1969-05-12 1974-05-07 Griffith Laboratories Methods of making vegetable protein concentrates
AU1589492A (en) 1991-03-01 1992-10-06 Warner-Lambert Company Starch-based controlled release compositions
US20120164306A1 (en) * 1993-08-03 2012-06-28 Girsh Leonard S Process for preparing hypoallergenic and reduced fat foods
JP3445593B2 (ja) * 1994-09-10 2003-09-08 株式会社林原生物化学研究所 ペプチドとその用途
AU1951201A (en) 1999-12-06 2001-06-12 Mount Sinai School Of Medicine Of The City University Of New York, The Peptide antigens
AU1951001A (en) 2000-04-06 2001-09-17 Panacea Pharm Llc Microbial delivery system
MXPA05009079A (es) * 2003-02-28 2006-05-19 Alk Abello As Forma de dosificacion que tiene una matriz de sacarido.
WO2005092360A1 (en) * 2004-03-19 2005-10-06 Xiu-Min Li Herbal therapy for the treatment of food allergy
JP2009522258A (ja) * 2005-12-28 2009-06-11 テバ ファーマシューティカル インダストリーズ リミティド 増大したバイオアベイラビリティを有するフェノフィブラートの医薬製剤
FR2924349B1 (fr) * 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
WO2010059534A2 (en) 2008-11-19 2010-05-27 Mallinckrodt Baker, Inc. Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
WO2010069595A1 (en) 2008-12-19 2010-06-24 Merz Pharma Gmbh & Co. Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
US8329208B2 (en) * 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
EP2364690A1 (en) * 2010-02-12 2011-09-14 Centro De Ingenieria Genetica Y Biotecnologia Orally administrable pharmaceutical pellet of epidermal growth factor
JP5800527B2 (ja) * 2010-03-30 2015-10-28 日東電工株式会社 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
AR081776A1 (es) 2010-06-30 2012-10-17 Novartis Ag Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, proceso para la produccion de la composicion
CN101912364B (zh) * 2010-08-09 2015-07-15 刘会梅 银杏内酯b脂质体组合药物
GB201104537D0 (en) 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
CA2846858C (en) * 2011-08-31 2022-03-08 Perosphere, Inc. Methods for effectively and rapidly desensitizing allergic patients
WO2013087119A1 (en) 2011-12-16 2013-06-20 Hal Allergy Holding B.V. Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
US9492535B2 (en) * 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
PL2968529T3 (pl) * 2013-03-14 2021-04-19 Aimmune Therapeutics, Inc. Wytwarzanie formulacji orzeszków ziemnych do doustnego odczulania
US11197896B2 (en) 2014-08-25 2021-12-14 Société des Produits Nestlé S.A. Egg protein formulations and methods of manufacture thereof
CN110381749A (zh) 2017-01-13 2019-10-25 艾慕恩治疗公司 坚果粉的制造方法和用于口服免疫疗法的配方
KR102753602B1 (ko) 2017-11-02 2025-01-10 에이뮨 테라퓨틱스, 인코퍼레이티드 경구 면역요법 방법

Also Published As

Publication number Publication date
CN109125283A (zh) 2019-01-04
AU2014240404B2 (en) 2016-07-21
AU2020202685B2 (en) 2022-01-20
EP2968529A4 (en) 2016-10-05
EP2968529B1 (en) 2020-08-05
SI2968529T1 (sl) 2021-03-31
US9198869B2 (en) 2015-12-01
AU2016231523A1 (en) 2016-10-06
JP6752140B2 (ja) 2020-09-09
CN105101994A (zh) 2015-11-25
FR23C1026I2 (fr) 2024-07-26
AU2022201858B2 (en) 2024-04-04
CN105101994B (zh) 2018-10-12
FI3482771T3 (fi) 2023-04-03
FR23C1026I1 (fr) 2023-10-06
JP7454519B2 (ja) 2024-03-22
EP3482771A1 (en) 2019-05-15
CA2903229A1 (en) 2014-10-02
BR112015021756A2 (pt) 2017-07-18
US20200129378A1 (en) 2020-04-30
JP2019108357A (ja) 2019-07-04
JP2021073321A (ja) 2021-05-13
AU2020202685A1 (en) 2020-05-14
AU2014240404A1 (en) 2015-09-17
JP6891205B2 (ja) 2021-06-18
US10449118B2 (en) 2019-10-22
US20140271836A1 (en) 2014-09-18
BR112015021756A8 (pt) 2019-11-19
US20160030289A1 (en) 2016-02-04
US20230120350A1 (en) 2023-04-20
JP2016512537A (ja) 2016-04-28
ES2826224T3 (es) 2021-05-17
DK3482771T3 (da) 2023-03-20
US20180042816A1 (en) 2018-02-15
AU2018222980A1 (en) 2018-09-20
PL2968529T3 (pl) 2021-04-19
US11141352B2 (en) 2021-10-12
HUE051831T2 (hu) 2021-03-29
AU2022201858A1 (en) 2022-04-07
EP2968529A1 (en) 2016-01-20
ES2940686T3 (es) 2023-05-10
PT2968529T (pt) 2020-11-10
DK2968529T3 (da) 2020-10-12
NO2023027I1 (no) 2023-07-06
EP3998080A1 (en) 2022-05-18
BR112015021756B1 (pt) 2023-01-10
HK1217660A1 (zh) 2017-01-20
FIC20230022I1 (fi) 2023-07-04
EP3482771B1 (en) 2023-01-18
AU2016231523B2 (en) 2018-05-31
WO2014159607A1 (en) 2014-10-02

Similar Documents

Publication Publication Date Title
MX2015010315A (es) Fabricacion de formulaciones de mani para desensibilizacion oral.
IL263175B (en) Microbiota restoration therapy (mrt), compositions and methods of manufacture
PH12015501435A1 (en) Oral care products comprising a tetrabasic zinc - amino acid - halide complex
AU2014247175A8 (en) Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5 and methods of use
MX2019008419A (es) Métodos de fabricación de harinas de nueces y formulaciones para inmunoterapia oral.
EP3053185A4 (en) Internal spacers for nanowire transistors and method of fabrication thereof
EP3014496A4 (en) Additive manufacturing system and method of manufacture
EP3036354A4 (en) Proppant material incorporating fly ash and method of manufacture
EP3003207A4 (en) Dental appliance system and method of manufacture
EP2991108A4 (en) Semiconductor device and method of manufacture thereof
EP3078109A4 (en) Power suppy and method of manufacturing
SG11201507643PA (en) Moldable capsule and method of manufacture
EP3083939A4 (en) Compositions for cellular restoration and methods of making and using same
HUE042667T2 (hu) Proenzimek és enzimek keverékét tartalmazó gyógyszerészeti összetétel
EP3025720A4 (en) Preparation method for therapeutic agent of bead-type chondrocyte
EP3160299A4 (en) Oral care implement and method of manufacturing an oral care implement
EP2994483A4 (en) Methods and compositions related to large scale production of proteins
EP3019446A4 (en) New form of silicon and method of making the same
EP3057992A4 (en) Human antibody against aggrecanase-type adamts species for therapeutics of aggrecanase-related diseases
ZA201507881B (en) Coated chewing gum and its process of manufacture
IN2013CH05282A (es)
AR091136A1 (es) Metodo de cementado y composicion fraguable
HK40100453A (en) Microbiota restoration therapy (mrt), compositions and methods of manufacture
NZ767226A (en) Egg protein formulations and methods of manufacture thereof
IN2013CH04892A (es)